g4426b Search Results


bv786 mouse anti-human cd44 (clone: g4426) (1:20 dilution)  (Becton Dickinson)
90
Becton Dickinson bv786 mouse anti-human cd44 (clone: g4426) (1:20 dilution)
CD24, <t>CD44,</t> and ALDH expression in oral tumors (A) Gating strategy has been shown. (B) (i) Gate 1 shows all intact cells with high-FSC and SCC parameters. Cell debris with low-FSC and SCC as well as aggregates/ large cells with very high FSC and/or SCC values were excluded. B (ii, iii) Gate 2 and 3 were made to include only singlet cell population. B (iv) Live cells were included for analysis by drawing a viable gate for propidium iodide negative population. (C) Using DEAB-control and isotype control antibody, gates for lineage negative as in C (i), <t>CD24/CD44</t> negative as in C (ii) and ALDH-Low as in C (iii) population is shown. (D) APC-conjugated lineage antibody cocktail mixed with CD31-APC was used to separate lineage marker-positive and CD31-positive cells. Lineage antibody-negative gate was drawn for including and analyzing lineage marker and CD31-negative tumor cells (D-i). From this gate, cells populated in respective gates are shown for <t>CD24/CD44</t> expression (D-ii), ALHD-High and Low (D-iii) and CD24/CD44 expressing cells with ALDH-High phenotype (D-iv).
Bv786 Mouse Anti Human Cd44 (Clone: G4426) (1:20 Dilution), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bv786 mouse anti-human cd44 (clone: g4426) (1:20 dilution)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
bv786 mouse anti-human cd44 (clone: g4426) (1:20 dilution) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anti-cd44-apc  (Becton Dickinson)
90
Becton Dickinson anti-cd44-apc
CD24, <t>CD44,</t> and ALDH expression in oral tumors (A) Gating strategy has been shown. (B) (i) Gate 1 shows all intact cells with high-FSC and SCC parameters. Cell debris with low-FSC and SCC as well as aggregates/ large cells with very high FSC and/or SCC values were excluded. B (ii, iii) Gate 2 and 3 were made to include only singlet cell population. B (iv) Live cells were included for analysis by drawing a viable gate for propidium iodide negative population. (C) Using DEAB-control and isotype control antibody, gates for lineage negative as in C (i), <t>CD24/CD44</t> negative as in C (ii) and ALDH-Low as in C (iii) population is shown. (D) APC-conjugated lineage antibody cocktail mixed with CD31-APC was used to separate lineage marker-positive and CD31-positive cells. Lineage antibody-negative gate was drawn for including and analyzing lineage marker and CD31-negative tumor cells (D-i). From this gate, cells populated in respective gates are shown for <t>CD24/CD44</t> expression (D-ii), ALHD-High and Low (D-iii) and CD24/CD44 expressing cells with ALDH-High phenotype (D-iv).
Anti Cd44 Apc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd44-apc/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-cd44-apc - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
monoclonal anti-cd44-fluorescein isothiocyanate g4426  (Becton Dickinson)
90
Becton Dickinson monoclonal anti-cd44-fluorescein isothiocyanate g4426
CD24, <t>CD44,</t> and ALDH expression in oral tumors (A) Gating strategy has been shown. (B) (i) Gate 1 shows all intact cells with high-FSC and SCC parameters. Cell debris with low-FSC and SCC as well as aggregates/ large cells with very high FSC and/or SCC values were excluded. B (ii, iii) Gate 2 and 3 were made to include only singlet cell population. B (iv) Live cells were included for analysis by drawing a viable gate for propidium iodide negative population. (C) Using DEAB-control and isotype control antibody, gates for lineage negative as in C (i), <t>CD24/CD44</t> negative as in C (ii) and ALDH-Low as in C (iii) population is shown. (D) APC-conjugated lineage antibody cocktail mixed with CD31-APC was used to separate lineage marker-positive and CD31-positive cells. Lineage antibody-negative gate was drawn for including and analyzing lineage marker and CD31-negative tumor cells (D-i). From this gate, cells populated in respective gates are shown for <t>CD24/CD44</t> expression (D-ii), ALHD-High and Low (D-iii) and CD24/CD44 expressing cells with ALDH-High phenotype (D-iv).
Monoclonal Anti Cd44 Fluorescein Isothiocyanate G4426, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-cd44-fluorescein isothiocyanate g4426/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
monoclonal anti-cd44-fluorescein isothiocyanate g4426 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


CD24, CD44, and ALDH expression in oral tumors (A) Gating strategy has been shown. (B) (i) Gate 1 shows all intact cells with high-FSC and SCC parameters. Cell debris with low-FSC and SCC as well as aggregates/ large cells with very high FSC and/or SCC values were excluded. B (ii, iii) Gate 2 and 3 were made to include only singlet cell population. B (iv) Live cells were included for analysis by drawing a viable gate for propidium iodide negative population. (C) Using DEAB-control and isotype control antibody, gates for lineage negative as in C (i), CD24/CD44 negative as in C (ii) and ALDH-Low as in C (iii) population is shown. (D) APC-conjugated lineage antibody cocktail mixed with CD31-APC was used to separate lineage marker-positive and CD31-positive cells. Lineage antibody-negative gate was drawn for including and analyzing lineage marker and CD31-negative tumor cells (D-i). From this gate, cells populated in respective gates are shown for CD24/CD44 expression (D-ii), ALHD-High and Low (D-iii) and CD24/CD44 expressing cells with ALDH-High phenotype (D-iv).

Journal: STAR Protocols

Article Title: Characterizing diversity among human oral stem-like cancer cells using flow cytometry

doi: 10.1016/j.xpro.2022.101763

Figure Lengend Snippet: CD24, CD44, and ALDH expression in oral tumors (A) Gating strategy has been shown. (B) (i) Gate 1 shows all intact cells with high-FSC and SCC parameters. Cell debris with low-FSC and SCC as well as aggregates/ large cells with very high FSC and/or SCC values were excluded. B (ii, iii) Gate 2 and 3 were made to include only singlet cell population. B (iv) Live cells were included for analysis by drawing a viable gate for propidium iodide negative population. (C) Using DEAB-control and isotype control antibody, gates for lineage negative as in C (i), CD24/CD44 negative as in C (ii) and ALDH-Low as in C (iii) population is shown. (D) APC-conjugated lineage antibody cocktail mixed with CD31-APC was used to separate lineage marker-positive and CD31-positive cells. Lineage antibody-negative gate was drawn for including and analyzing lineage marker and CD31-negative tumor cells (D-i). From this gate, cells populated in respective gates are shown for CD24/CD44 expression (D-ii), ALHD-High and Low (D-iii) and CD24/CD44 expressing cells with ALDH-High phenotype (D-iv).

Article Snippet: BV786 Mouse Anti-Human CD44 (Clone: G4426) (1:20 dilution) , BD Biosciences , Cat#564942.

Techniques: Expressing, Marker

Journal: STAR Protocols

Article Title: Characterizing diversity among human oral stem-like cancer cells using flow cytometry

doi: 10.1016/j.xpro.2022.101763

Figure Lengend Snippet:

Article Snippet: BV786 Mouse Anti-Human CD44 (Clone: G4426) (1:20 dilution) , BD Biosciences , Cat#564942.

Techniques: Blocking Assay, Recombinant, Software, Cell Culture, Inverted Microscopy, Imaging